A detailed history of Benjamin Edwards Inc transactions in Twist Bioscience Corp stock. As of the latest transaction made, Benjamin Edwards Inc holds 196 shares of TWST stock, worth $9,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
196
Previous 144 36.11%
Holding current value
$9,898
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$32.28 - $41.5 $1,678 - $2,158
52 Added 36.11%
196 $7,000
Q4 2023

Feb 06, 2024

SELL
$15.08 - $38.61 $1,628 - $4,169
-108 Reduced 42.86%
144 $5,000
Q2 2023

Aug 15, 2023

BUY
$11.49 - $20.46 $666 - $1,186
58 Added 29.9%
252 $5,000
Q1 2023

Apr 27, 2023

BUY
$14.6 - $30.9 $2,219 - $4,696
152 Added 361.9%
194 $3,000
Q4 2022

Feb 07, 2023

BUY
$21.92 - $39.37 $920 - $1,653
42 New
42 $1,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.85B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.